EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Antiviral activities of hemp cannabinoids

Richard B van Breemen iD, Daniel Simchuk

Clinical Science · 2023

DOI: 10.1042/cs20220193 ↗

At a glance

Journal article in Clinical Science, 2023. Written by Richard B van Breemen and 1 co-authors. Institution: Department of Pharmaceutical Sciences, College of Pharmacy, Linus Pauling Institute, Global Hemp Innovation Center, Oregon State University, 2900 SW …. Major MEDLINE topics: Cannabis, COVID-19, Cannabinoids, Cannabidiol. Cited 13 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hemp is an understudied source of pharmacologically active compounds and many unique plant secondary metabolites including more than 100 cannabinoids. After years of legal restriction, research on hemp has recently demonstrated antiviral activities in silico, in vitro, and in vivo for cannabidiol (CBD), Δ9-tetrahydrocannabinol (Δ9-THC), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), and several other cannabinoids against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), human immunodeficiency virus (HIV), and γ-herpes viruses. Mechanisms of action include inhibition of viral cell entry, inhibition of viral proteases, and stimulation of cellular innate immune responses. The anti-inflammatory properties of cannabinoids are also under investigation for mitigating the cytokine storm of COVID-19 and controlling chronic inflammation in people living with HIV. Retrospective clinical studies support antiviral activities of CBD, Δ9-THC, and cannabinoid mixtures as do some prospective clinical trials, but appropriately designed clinical trials of safety and efficacy of antiviral cannabinoids are urgently needed.

Subjects

MeSH terms (MEDLINE)

CannabisCOVID-19CannabinoidsCannabidiolHIV InfectionsHumansProspective StudiesRetrospective StudiesSARS-CoV-2

Author keywords

COVID-19HIVSARS-CoV-2antiviralcannabinoidsherpesvirus

Substances

CannabinoidsCannabidiol

Authors and institutions

  • Department of Pharmaceutical Sciences, College of Pharmacy, Linus Pauling Institute, Global Hemp Innovation Center, Oregon State University, 2900 SW Campus Drive, Corvallis, OR 97331, U.S.A.

ORCID profiles: Richard B van Breemen

Cite

APA

van Breemen, R. B., & Simchuk, D. (2023). Antiviral activities of hemp cannabinoids. Clinical Science. https://doi.org/10.1042/cs20220193

Vancouver

van Breemen RB, Simchuk D. Antiviral activities of hemp cannabinoids. Clinical Science. 2023. doi:10.1042/cs20220193

BibTeX
@article{vanBreemen2023,
  author = {van Breemen, Richard B and Simchuk, Daniel},
  title = {Antiviral activities of hemp cannabinoids},
  journal = {Clinical Science},
  year = {2023},
  doi = {10.1042/cs20220193}
}
Start for free →